Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Acurx Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get ACXP alerts

About David P. Luci

David P. Luci is recorded as Board Member and CEO at Acurx Pharmaceuticals, Inc. (ACXP). The newest filing on record that lists David P. Luci as Board Member and CEO at Acurx Pharmaceuticals, Inc. (ACXP) is dated September 1, 2026. The proxy statement of Acurx Pharmaceuticals, Inc. reports total compensation of $1,431,383 for David P. Luci in fiscal 2024, including a base salary of $537,508. Disclosed compensation is on record for 5 fiscal years. Acurx Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acurx Pharmaceuticals, Inc. includes Robert DeLuccia (Chairman), Carl V. Sailer (Board Member), Jack H. Dean (Board Member) and 2 others.

Affiliation history

Company network

Leadership on record at Acurx Pharmaceuticals, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Acurx Pharmaceuticals, Inc. (ACXP) $537,508 $1,431,383
2023 Acurx Pharmaceuticals, Inc. (ACXP) $475,000 $1,023,878
2022 Acurx Pharmaceuticals, Inc. (ACXP) $475,000 $655,000
2021 Acurx Pharmaceuticals, Inc. (ACXP) $363,500 $4,487,465
2020 Acurx Pharmaceuticals, Inc. (ACXP) $277,000 $596,037

Recent activity

No call appearances or filed executive changes recorded yet.